Masimo Corporation

Masimo Corporation develops, manufactures, and markets patient monitoring technologies, as well as automation and connectivity solutions. Its flagship product is Masimo Signal Extraction Technology (SET) pulse oximetry, which provides accurate monitoring even during patient motion and low perfusion. The company also offers the Masimo Rainbow SET platform for noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, brain function, and hemodynamics. Additionally, Masimo provides hospital automation solutions such as Patient SafetyNet, Iris, and UniView, along with brain function monitoring, capnography, and telehealth solutions. Its products are used in hospitals, emergency medical services, home care, long-term care, physician offices, and veterinary settings.

Masimo Corporation is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol MASI. Its shares are traded in US Dollars (USD), as the company is based in the United States. The exchange is one of the major US stock exchanges, providing liquidity and visibility for investors.

Masimo operates in the Healthcare sector, specifically within the Medical Devices industry. This means the company designs, manufactures, and sells medical equipment and technologies used by healthcare professionals to monitor patients' vital signs and improve clinical outcomes. As a medical device company, Masimo focuses on noninvasive monitoring solutions, including pulse oximetry and brain function monitoring, which are critical in various care settings.

Masimo Corporation is headquartered in Irvine, California, United States. The company serves a global market, providing its patient monitoring technologies and automation solutions to hospitals, emergency medical services, home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Its products are distributed through a direct sales force, distributors, and OEM partners worldwide.

Masimo generates revenue by selling its patient monitoring technologies, automation platforms, and connectivity solutions. Key product lines include Masimo SET pulse oximetry, Rainbow SET Pulse CO-Oximetry, and hospital automation systems like Patient SafetyNet and Iris. The company sells directly to healthcare providers and also through distributors and OEM partners. Its customer base spans hospitals, emergency services, home care, long-term care, physician offices, and veterinary clinics. Additionally, Masimo offers telehealth solutions, contributing to its revenue stream.